From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
October 27, 2015
Philadelphia, PA – October 27, 2015 – IntegriChain, a rapidly growing cloud company focused on channel management for healthcare suppliers, today announced the launch of the hybrid IntegriChain Cloud to meet the growing demands of big data and analytics for the healthcare channel. According to IDC, in 2012, 2.8 trillion gigabytes of data were generated; by 2020, it will be 40 trillion gigabytes and the vast majority will be unstructured and user-generated. The hybrid IntegriChain Cloud is designed to address the scalability, capacity, and security demands for the rapidly increasing volume and variety of big data for healthcare channel management.
“Big data is exploding and has become a critical component of daily business management for healthcare manufacturers,” said Kevin Leininger, co-founder and Chief Executive Officer of IntegriChain. “At IntegriChain, we process more than $200 billion dollars in healthcare commerce through our cloud annually and maintain a forward-thinking strategy for our technology infrastructure to ensure that we can meet the skyrocketing demands for data processing and deliver world-class channel management analytics and applications. The hybrid IntegriChain Cloud allows us to leverage big data science – which will increasingly include anonymized patient-level data, serialized data, as well as order plans to drive predictive order analytics – driving the ability for our customers to progress from insight to action quickly for collaborative channel management.”
The hybrid IntegriChain Cloud encompasses both the existing IntegriChain private cloud, which includes IntegriChain user networks and the IntegriChain data centers, along with public cloud services through Amazon Web Services (AWS). AWS is the data analysis technology choice of more than one million active customers across 190 countries including global leaders in multiple industries such as Comcast, Shell, Ticketmaster, NASA, NASDAQ, Thomson Reuters, and Netflix. AWS offers IntegriChain customers global reach, premier storage and analysis services, and the highest levels of security (including HIPAA and SOC 2), auditing, and compliance. The launch of the hybrid IntegriChain Cloud will be seamless for IntegriChain customers.
About IntegriChain IntegriChain is the leading channel management cloud used by healthcare suppliers, including nine of the top-10 pharmaceutical manufacturers, to drive channel collaboration and to improve the efficiency of how products reach customers. Pharmaceutical, biopharm/specialty pharma, generics, and consumer health suppliers use IntegriChain to manage their supply chain relationships, inventories, and orders across a vast network of retailers, ecommerce, and distributors. As a suite of informed applications and analytics built on top of aggregated channel inventory and point-of-sale (POS) data, IntegriChain provides customer operations, national accounts, and finance teams with a collaborative, agile, and mobile alternative to ERP and homegrown systems. By embedding big-data customer insights into daily business processes, IntegriChain helps control the high cost of product distribution while improving product availability, ensuring a higher level of revenue predictability and maximizing distribution investment. More than $200 billion in annual US commerce and 2.0 billion transactions flowed through the IntegriChain Cloud in 2014. For more information, visit www.integrichain.com and follow us on Twitter @IntegriChain.
###
IntegriChain is a registered trademark of IntegriChain Incorporated. All other trademarks are property of their respective owners.
Contacts Jennifer Guinan | Sage Strategic Marketing 610.410.8111 Jennifer@sagestrat.com
Save the date!
Webinars & Resources
See List
